Mechanisms of ghrelin anti-heart failure: Inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Yang, Chunyan ^a   Liu, Zhonghui ^a,b   Liu, Kai ^a   Yang, Ping ^a  

^a JILIN UNIVERSITY   (China)

^b Basic Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; GHRELIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART CELL CULTURE; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; TREATMENT DURATION; UPREGULATION;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 3; DOWN-REGULATION; FEMALE; GHRELIN; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RNA, MESSENGER;

EID: 84905266375     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085785     Document Type: Article

References (30)

1. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Takeshita A, et al. (2007) Characteristics and outcomes of patients with heart failure in general practices and hospitals. Circ J 71: 449-454.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, et al. (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146.
3. Kang PM, Izumo S (2000) Apoptosis and Heart Failure: A Critical Review of the Literature. Circ Res 86: 1107-1113. (Pubitemid 30396034)
4. Nishida K, Otsu K (2008) Cell Death in Heart Failure. Circ J 72 Suppl A: A17-A21.
5. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111: 1497-1504. (Pubitemid 38063282)
6. van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, et al. (2005) De Windt. Myocyte apoptosis in heart failure. Cardiovasc Res 67: 21-29. (Pubitemid 40798289)
7. Lee Y, Gustafsson AB (2009) Role of apoptosis in cardiovascular disease. Apoptosis 14: 536-548.
8. Unger T, Li J (2004) The role of the renin-angiotensin-aldosterone system in heart failure. J Renin Angiotensin Aldosterone Syst 5 Suppl 1: S7-S10. (Pubitemid 39406441)
9. Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, et al. (2009) AngiotensinII type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc Res 81: 592-600.
10. Mel'nikova NP, Timoshin SS, Jivotova EY, Pelliniemi LJ, Jokinen E, et al. (2006) Angiotensin-II activates apoptosis, proliferation and protein synthesis in the left heart ventricle of newborn albino rats. Int J Cardiol 112: 219-222. (Pubitemid 44353796)
11. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H,et al. (1994) Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 267: H844-H852.
12. Wollert KC, Drexler H (1999) The renin-angiotensin system and experimental heart failure. Cardiovasc Res 43: 838-849. (Pubitemid 29413183)
13. Lemarié CA, Schiffrin EL (2010) The angiotensin II type 2 receptor in cardiovascular disease. J Renin Angiotensin Aldosterone Syst 11: 19-31.
14. Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, Shainberg A (2001) Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens 19: 1681-1689. (Pubitemid 32783788)
15. Qi Y, Li H, Shenoy V, Li Q, Wong F, Zhang L, et al. (2012) Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury. Exp Physiol 97: 89-101.
16. Dell'Italia LJ (2011) Translational Success Stories: Angiotensin Receptor 1 Antagonists in Heart Failure. Circ. Res 109: 437-452.
17. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660. (Pubitemid 129516334)
18. Kojima M, Hosoda H, Matsuo H, Kangawa K (2001) Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12:118-122. (Pubitemid 33714199)
19. Chang L, Ren Y, Liu X, Li WG, Yang J, et al. (2004) Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 43: 165-170. (Pubitemid 38129672)
20. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, et al. (2001) Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104: 1430-1435. (Pubitemid 32880158)
21. Ledderose C, Kreth S, Beiras-Fernandez A (2011) Ghrelin, a novel peptide hormone in the regulation of energy balance and cardiovascular function. Recent Pat Endocr Metab Immune Drug Discov 5: 1-6.
22. Yang C, Wang Y, Liu H, Li N, Sun Y, et al. (2012) Ghrelin protects H9c2 cardiomyocytes from angiotensin II-induced apoptosis through the endoplasmic reticulum stress pathway. J Cardiovasc Pharmacol 59: 465-471.
23. Pettersson I, Muccioli G, Granata R, Deghenghi R, Ghigo E, et al. (2002) Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation. J Endocrinol 175: 201-209. (Pubitemid 35282394)
24. van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, et al. (2006) Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 106: 367-372. (Pubitemid 41766640)
25. Ukkola O, Pääkkö T, Kesäniemi YA (2012) Ghrelin and its promoter variant associated with cardiac hypertrophy. J Hum Hypertens 26: 452-457.
26. Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, et al. (2008) Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 294: H426-H432.
27. Xu JP, Wang HX, Wang W, Zhang LK, Tang CS (2010) Ghrelin improves disturbed myocardial energy metabolism in rats with heart failure induced by isoproterenol. J Pept Sci 16: 392-402.
28. Kuranaga E (2012) Beyond apoptosis: caspase regulatory mechanisms and functions in vivo. Genes Cells 17: 83-97.
29. Hurst PR, Mora JM, Fenwick MA (2006) Caspase-3, TUNEL and ultrastructural studies of small follicles in adult human ovarian biopsies. Hum Reprod 21: 1974-1980. (Pubitemid 44288069)
30. Schröder D, Heger J, Piper HM, Euler G (2006) Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J Mol Med (Berl) 84: 975-983. (Pubitemid 44655875)